TuHURA BIOSCIENCES, INC./NV Legal Fees
TuHURA BIOSCIENCES, INC./NV (HURA) reported Legal Fees of $1.55 million for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2022-09-27
- TuHURA BIOSCIENCES, INC./NV legal fees for the quarter ending 2021-06-30 was -$1.05M.
- TuHURA BIOSCIENCES, INC./NV legal fees for the quarter ending 2021-03-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV legal fees for the quarter ending 2020-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV legal fees for the quarter ending 2020-09-30 was $1.55M.
- TuHURA BIOSCIENCES, INC./NV legal fees for fiscal 2022 was $1.55M, a 210.80% increase from fiscal 2021.
- TuHURA BIOSCIENCES, INC./NV legal fees for fiscal 2021 was $500.00K, a 52.56% decline from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV legal fees for fiscal 2020 was $1.05M.
| Period end | Legal Fees 3 month | Legal Fees 3 month as first filed | Legal Fees 6 month | Legal Fees 6 month as first filed | Legal Fees 9 month | Legal Fees 9 month as first filed | Legal Fees 12 month | Legal Fees 12 month as first filed | Legal Fees 24 month |
|---|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | $1.55M 10-K · filed 2022-09-27 | ||||||||
| 2021-06-30 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | -$1.05M derived: sum of 2 quarters · filed 2022-05-13 | -$1.05M derived: sum of 3 quarters · filed 2022-05-13 | $500.00K 10-K · filed 2021-09-28 | $1.55M 10-K · filed 2021-09-28 | ||||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $1.55M 10-Q · filed 2022-05-13 | $1.55M 10-Q · filed 2021-05-13 | |||||
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $1.55M 10-Q · filed 2022-02-11 | $1.55M 10-Q · filed 2021-02-12 | ||||||
| 2020-09-30 | $1.55M 10-Q · filed 2021-11-15 | $1.55M 10-Q · filed 2020-11-12 | |||||||
| 2020-06-30 | $1.05M 10-K · filed 2021-09-28 | $1.10M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |